title: Re: Cho et al. "Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation".
authors.affiliation: Gulhane Military Medical Academy, Haydarpasa Training Hospital, Naval Academy Clinic, Tuzla, Istanbul, 34940, Turkey. dracakir@gmail.com.
authors.forename: Akin
authors.initials: A
authors.lastname: Cakir
authors.affiliation: Gumussuyu Military Hospital, Eye service, Taksim, İstanbul, Turkey.
authors.forename: Eyup
authors.initials: E
authors.lastname: Duzgun
mesh_terms: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005451:Fluorescein Angiography; D006801:Humans; D058449:Intravitreal Injections; D011379:Prognosis; D012160:Retina; D015861:Retinal Neovascularization; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A; D014792:Visual Acuity; D057135:Wet Macular Degeneration
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab